PMAM
Picton Mahoney Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,684
| Closed | -$5.95M | – | 950 |
|
|
2024
Q2 | $5.95M | Sell |
12,684
-21
| -0.2% | -$9.84K | 0.23% | 132 |
|
|
2024
Q1 | $5.31M | Sell |
12,705
-1,482
| -10% | -$620K | 0.16% | 133 |
|
|
2023
Q4 | $5.77M | Sell |
14,187
-510
| -3% | -$207K | 0.16% | 120 |
|
|
2023
Q3 | $5.11M | Buy |
14,697
+707
| +5% | +$246K | 0.15% | 128 |
|
|
2023
Q2 | $4.92M | Buy |
13,990
+444
| +3% | +$156K | 0.21% | 133 |
|
|
2023
Q1 | $4.27M | Sell |
13,546
-20
| -0.1% | -$6.3K | 0.19% | 153 |
|
|
2022
Q4 | $3.92M | Buy |
13,566
+326
| +2% | +$94.2K | 0.18% | 150 |
|
|
2022
Q3 | $3.83M | Buy |
13,240
+3,505
| +36% | +$1.01M | 0.14% | 146 |
|
|
2022
Q2 | $2.75M | Buy |
+9,735
| New | +$2.75M | 0.1% | 286 |
|
|
2021
Q3 | – | Sell |
-8,620
| Closed | -$1.74M | – | 940 |
|
|
2021
Q2 | $1.74M | Buy |
+8,620
| New | +$1.74M | 0.05% | 402 |
|
|
2021
Q1 | – | Sell |
-34,670
| Closed | -$8.19M | – | 387 |
|
|
2020
Q4 | $8.19M | Sell |
34,670
-26,944
| -44% | -$6.37M | 0.39% | 77 |
|
|
2020
Q3 | $16.8M | Sell |
61,614
-27,090
| -31% | -$7.37M | 0.93% | 20 |
|
|
2020
Q2 | $25.8M | Sell |
88,704
-28,802
| -25% | -$8.36M | 1.48% | 9 |
|
|
2020
Q1 | $28M | Sell |
117,506
-14,447
| -11% | -$3.44M | 1.58% | 7 |
|
|
2019
Q4 | $28.9M | Sell |
131,953
-1,047
| -0.8% | -$229K | 1.95% | 9 |
|
|
2019
Q3 | $22.5M | Sell |
133,000
-15,639
| -11% | -$2.65M | 1.59% | 17 |
|
|
2019
Q2 | $27.3M | Buy |
148,639
+44,355
| +43% | +$8.13M | 1.87% | 9 |
|
|
2019
Q1 | $19.2M | Buy |
104,284
+820
| +0.8% | +$151K | 1.45% | 21 |
|
|
2018
Q4 | $17.1M | Buy |
103,464
+3,023
| +3% | +$501K | 1.53% | 17 |
|
|
2018
Q3 | $19.4M | Sell |
100,441
-759
| -0.8% | -$146K | 1.36% | 23 |
|
|
2018
Q2 | $17.2M | Buy |
101,200
+4,100
| +4% | +$697K | 1.24% | 23 |
|
|
2018
Q1 | $15.8M | Buy |
97,100
+3,200
| +3% | +$522K | 1.14% | 28 |
|
|
2017
Q4 | $14.1M | Buy |
93,900
+7,900
| +9% | +$1.18M | 1.01% | 38 |
|
|
2017
Q3 | $13.1M | Buy |
+86,000
| New | +$13.1M | 0.98% | 36 |
|